Medium urgency

CBP Outlines Rates, Classifications For Pharma Tariffs - Law360

Detected July 31, 2026 · in Small Cross-Border Importers

CBP has published new rates and classifications for pharmaceutical tariffs, affecting importers of pharma products.

Aforeworn detected this change in the Small Cross-Border Importers space on July 31, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Importers of pharmaceutical products, including those sourcing from China and other countries. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Small Cross-Border Importers continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

New tariff rates and HS classifications for pharmaceutical products have been outlined by CBP.

Who it affects

Importers of pharmaceutical products, including those sourcing from China and other countries.

What you must do

Review the new rates and classifications to determine if your products are affected and adjust import planning.

Deadline

Not specified in the provided text.

Source: https://news.google.com/rss/articles/CBMiaEFVX3lxTE9qSk9ZSTFjeXZOMy1lNnhjT3VYc3BBdjVoZk03LWxYVDliZGhIYlBQR1VwZTc4V2pWWW5TbVppTFFvZ2s3TmR5aHF3bHJYNzhGRTNWdHRtellHbk1sUzhicmZVa1hKZExZ0gFoQVVfeXFMT2pKT1lJMWN5dk4zLWU2eGNPdVhzcEF2NWhmTTctbFhUOWJkaEhiUFBHVXBlNzhXalZZblNtWmlMUW9nazdOZHlocXdsclg3OEZFM1Z0dG16WUduTWxTOGJyZlVrWEpkTFk?oc=5

Never miss a change like this again

Aforeworn watches Small Cross-Border Importers around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Small Cross-Border Importers